• Investigate if acupuncture is effective in preventing xerostomia among cancer patients at Fudan University Cancer Hospital (Cancer Hospital) who receive radiation treatment. [ Time Frame: 2 Years ] [ Designated as safety issue: No ]
  

• Determine whether acupuncture reduces the severity of xerostomia. [ Time Frame: 2 Years ] [ Designated as safety issue: No ]
  
• Determine the feasibility of providing acupuncture treatment to patients at Cancer Hospital who are receiving radiation treatment. [ Time Frame: 2 Years ] [ Designated as safety issue: No ]
  

Inclusion Criteria:

1. Adult >/= 18 year of age and able to sign informed consent
2. Diagnosed with nasopharyngeal carcinoma and scheduled to undergo concurrent chemotherapy and radiation treatment
3. Treatment plan must include treatment of at least 50 gray bilateral to the parotid
4. Must have anatomically intact parotid and submandibular glands
5. Karnofsky Performance Status > 60
6. If the participant is female and of child bearing potential, must have a negative urine pregnancy test.

Exclusion Criteria:

1. History of xerostomia prior to the head and neck radiation therapy (Sjögren's disease or other underlying systemic illness known to cause xerostomia).
2. Planned IMRT
3. Suspected or confirmed physical closure of salivary gland ducts on either side
4. Known bleeding disorders and on Heparin or Coumadin
5. Upper or lower extremity deformities that could interfere with accurate acupoint location or alter the energy pathway as defined by traditional acupuncture theory
6. Local skin infections at or near the acupuncture site or active systemic infection
7. History of cerebrovascular accident or spinal cord injury. (The mechanism of action for acupuncture may be associated with central nervous system (CNS) activity, and patients with CNS pathology may respond differently to treatment than the general population.)
8. Mental incapacitation or significant emotional or psychiatric disorder that, in the opinion of the investigator, precludes study entry as these patients may not be able to cooperate with this slightly invasive procedure or with the data collection process
9. Current acknowledged use of any illicit drugs or evidence of alcohol abuse as defined by The American Psychiatric Association criteria
10. Participants who are taking or who have taken any investigational new drug within the last 30 days, or who are planning to take such a drug during the course of the study
11. Current acknowledged use of other alternative medicines such as herbal preparations that could affect salivary function. Each patient will be asked for a list of herbal supplements they are currently taking and this will be reviewed on an individual basis. Patients will be excluded if they are taking any herbs known or suspected to affect salivary function
12. Participants taking cholinergic agonist medication (Pilocarpine, Cevimeline), beta adrenergic antagonists, anticholinergic agents or other medications known to affect salivary function
13. Currently receiving acupuncture for any condition
14. No prior head and neck radiation treatment